Cowen Prime Advisors LLC Exagen Inc. Transaction History

Cowen Prime Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$4.18 - $7.74 $413,402 - $765,486	-98,900 Reduced 99.5%	500 $3,000
Q1 2022 May 02, 2022	SELL	$7.12 - $11.06 $21,360 - $33,180	-3,000 Reduced 2.93%	99,400 $798,000
Q4 2021 Feb 08, 2022	SELL	$8.97 - $14.08 $722,085 - $1.13 Million	-80,500 Reduced 44.01%	102,400 $1.19 Million
Q3 2021 Nov 02, 2021	BUY	$10.25 - $15.21 $1.87 Million - $2.78 Million	182,900 New	182,900 $2.49 Million
Q2 2021 Aug 04, 2021	SELL	$12.4 - $17.92 $6,200 - $8,960	-500 Closed	0 $0
Q2 2020 Aug 01, 2022	BUY	$11.0 - $16.7 $5,500 - $8,350	500 New	500 $3,000

6.41M

4.5K

400

Ticker XGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 16,260,400
Market Cap $89.8M
Description
Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...

Get notified when there are updates to the investment portfolio of Cowen Prime Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Cowen Prime Advisors LLC with notifications on news.